ME02405B - Spojevi pirazola као inhibitori sglt1 - Google Patents
Spojevi pirazola као inhibitori sglt1Info
- Publication number
- ME02405B ME02405B MEP-2016-121A MEP2016121A ME02405B ME 02405 B ME02405 B ME 02405B ME P2016121 A MEP2016121 A ME P2016121A ME 02405 B ME02405 B ME 02405B
- Authority
- ME
- Montenegro
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- accordance
- intended
- Prior art date
Links
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 108091006277 SLC5A1 Proteins 0.000 title 1
- 102000058090 Sodium-Glucose Transporter 1 Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 8
- 150000003839 salts Chemical class 0.000 claims 7
- 239000000825 pharmaceutical preparation Substances 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
- C07H7/06—Heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261645101P | 2012-05-10 | 2012-05-10 | |
| US201361769221P | 2013-02-26 | 2013-02-26 | |
| EP13722231.1A EP2850084B1 (en) | 2012-05-10 | 2013-05-02 | Pyrazole compounds as sglt1 inhibitors |
| PCT/US2013/039164 WO2013169546A1 (en) | 2012-05-10 | 2013-05-02 | Pyrazole compounds as sglt1 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME02405B true ME02405B (me) | 2016-09-20 |
Family
ID=48428684
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2016-121A ME02405B (me) | 2012-05-10 | 2013-05-02 | Spojevi pirazola као inhibitori sglt1 |
Country Status (42)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 | |
| TW201425326A (zh) | 2012-10-05 | 2014-07-01 | Lilly Co Eli | 新穎脲化合物 |
| TWI633113B (zh) | 2013-10-17 | 2018-08-21 | 美國禮來大藥廠 | 新穎脲化合物 |
| AR098134A1 (es) | 2013-11-01 | 2016-05-04 | Lilly Co Eli | Compuestos de urea |
| AR098670A1 (es) * | 2013-11-08 | 2016-06-08 | Lilly Co Eli | Inhibidor de sglt1 |
| CN110054657B (zh) * | 2018-01-18 | 2021-06-29 | 亚宝药业集团股份有限公司 | 吡喃葡萄糖取代的吡唑化合物及其制备方法 |
| AU2019249560B2 (en) * | 2018-04-04 | 2023-10-05 | Japan Tobacco Inc. | Heteroaryl-substituted pyrazole compound and medicinal use thereof |
| EP4342466A1 (en) * | 2019-09-04 | 2024-03-27 | Japan Tobacco Inc. | Therapeutic or prophylactic method for diabetes using combination medicine |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ303372B6 (cs) | 1999-08-31 | 2012-08-22 | Kissei Pharmaceutical Co., Ltd. | Glukopyranosyloxypyrazolový derivát a farmaceutická kompozice s jeho obsahem a benzylpyrazolový meziprodukt |
| DE60230591D1 (de) | 2001-02-26 | 2009-02-12 | Kissei Pharmaceutical | Glykopyranosyloxypyrazolderivate und deren medizinische verwendung |
| EP1400529A4 (en) | 2001-05-30 | 2007-12-19 | Kissei Pharmaceutical | GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF |
| BRPI0313290B1 (pt) * | 2002-08-08 | 2016-12-06 | Kissei Pharmaceutical | derivados de pirazol, promedicamento, composição farmacêutica, agentes terapêuticos e uso medicinal |
| JP2004137245A (ja) | 2002-08-23 | 2004-05-13 | Kissei Pharmaceut Co Ltd | ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体 |
| DE102004028241B4 (de) * | 2004-06-11 | 2007-09-13 | Sanofi-Aventis Deutschland Gmbh | Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel |
| US7973012B2 (en) * | 2006-05-19 | 2011-07-05 | Taisho Pharmaceutical Co., Ltd | C-phenyl glycitol compound |
| BRPI0821773B8 (pt) | 2007-12-27 | 2021-05-25 | Kissei Pharmaceutical | monossebacato cristalino de bis[3-(3-{4-[3-(beta-dglicopiranosilóxi)-5-isopropil-1h-pirazol-4-ilmetil]-3-metilfenóxi}propilamino)-2,2-dimetil-propionamida], composição farmacêutica e medicamento compreendendo o dito composto |
| ES2397086T3 (es) | 2009-02-23 | 2013-03-04 | Taisho Pharmaceutical Co., Ltd. | Compuestos de 4-isopropilfenil glucitol como inhibidores de SGLT1 |
| JP2013506635A (ja) | 2009-10-02 | 2013-02-28 | サノフイ | 骨疾患を処置するための薬剤を製造するためのｓｇｌｔ−１／ｓｇｌｔ−２阻害剤活性を有する化合物の使用 |
| US8163704B2 (en) | 2009-10-20 | 2012-04-24 | Novartis Ag | Glycoside derivatives and uses thereof |
| UA113086C2 (xx) * | 2012-05-10 | 2016-12-12 | Піразольні сполуки як інгібітори sglt1 |
-
2013
- 2013-02-05 UA UAA201412088A patent/UA113086C2/uk unknown
- 2013-04-23 AR ARP130101348A patent/AR090806A1/es active IP Right Grant
- 2013-04-23 JO JOP/2013/0117A patent/JO3136B1/ar active
- 2013-04-25 TW TW102114877A patent/TWI579295B/zh active
- 2013-05-02 MY MYPI2014703279A patent/MY177326A/en unknown
- 2013-05-02 NZ NZ700356A patent/NZ700356A/en unknown
- 2013-05-02 PE PE2014001716A patent/PE20142399A1/es active IP Right Grant
- 2013-05-02 RS RS20160626A patent/RS55107B1/sr unknown
- 2013-05-02 AU AU2013259946A patent/AU2013259946B2/en active Active
- 2013-05-02 MX MX2014013615A patent/MX357058B/es active IP Right Grant
- 2013-05-02 EP EP13722231.1A patent/EP2850084B1/en active Active
- 2013-05-02 JP JP2015511518A patent/JP6148725B2/ja active Active
- 2013-05-02 KR KR1020147031119A patent/KR101685779B1/ko active Active
- 2013-05-02 PT PT137222311T patent/PT2850084T/pt unknown
- 2013-05-02 AP AP2014008044A patent/AP3593A/xx active
- 2013-05-02 HR HRP20160804TT patent/HRP20160804T1/hr unknown
- 2013-05-02 IN IN7996DEN2014 patent/IN2014DN07996A/en unknown
- 2013-05-02 US US13/875,314 patent/US8697849B2/en active Active
- 2013-05-02 CA CA2869323A patent/CA2869323C/en active Active
- 2013-05-02 SG SG11201407345QA patent/SG11201407345QA/en unknown
- 2013-05-02 EA EA201491852A patent/EA024207B1/ru not_active IP Right Cessation
- 2013-05-02 DK DK13722231.1T patent/DK2850084T3/en active
- 2013-05-02 LT LTEP13722231.1T patent/LT2850084T/lt unknown
- 2013-05-02 BR BR112014026198-9A patent/BR112014026198B1/pt active IP Right Grant
- 2013-05-02 HU HUE13722231A patent/HUE030414T2/en unknown
- 2013-05-02 SI SI201330209A patent/SI2850084T1/sl unknown
- 2013-05-02 ME MEP-2016-121A patent/ME02405B/me unknown
- 2013-05-02 WO PCT/US2013/039164 patent/WO2013169546A1/en not_active Ceased
- 2013-05-02 ES ES13722231.1T patent/ES2588835T3/es active Active
- 2013-05-02 PL PL13722231T patent/PL2850084T3/pl unknown
-
2014
- 2014-02-18 US US14/182,354 patent/US9296775B2/en active Active
- 2014-09-30 TN TNP2014000410A patent/TN2014000410A1/fr unknown
- 2014-10-10 CR CR20140473A patent/CR20140473A/es unknown
- 2014-10-16 ZA ZA2014/07531A patent/ZA201407531B/en unknown
- 2014-10-22 CL CL2014002845A patent/CL2014002845A1/es unknown
- 2014-10-30 IL IL235427A patent/IL235427A/en active IP Right Grant
- 2014-11-03 DO DO2014000250A patent/DOP2014000250A/es unknown
- 2014-11-05 MA MA37501A patent/MA37501B1/fr unknown
- 2014-11-05 GT GT201400242A patent/GT201400242A/es unknown
- 2014-11-07 EC ECIEPI201426088A patent/ECSP14026088A/es unknown
- 2014-11-07 PH PH12014502492A patent/PH12014502492A1/en unknown
- 2014-11-11 CO CO14249415A patent/CO7141429A2/es unknown
-
2016
- 2016-08-11 CY CY20161100801T patent/CY1117912T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| ME02910B (me) | Spojevi tetrahidropirolotiazina | |
| ME02405B (me) | Spojevi pirazola као inhibitori sglt1 | |
| FI3256218T3 (fi) | Kdm1a-estäjät sairauksien hoidossa | |
| HRP20171512T1 (hr) | Derivati betulina | |
| CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
| EA201592256A1 (ru) | Производные имидазопирролидинона и их применение при лечении заболеваний | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| MX355267B (es) | Análogos de carba-nucleósido 2´-sustituidos para tratamiento antivírico. | |
| MD4736B1 (ro) | Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| EA201690247A1 (ru) | Аминометилбиарильные производные-ингибиторы фактора d комплемента и их применения | |
| PH12015501993B1 (en) | Pyrazole-amide compound and medicinal uses therefor | |
| EA201592255A1 (ru) | Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания | |
| MX389600B (es) | Nueva composición terapéutica que contiene ingrediente activo de apomorfinas. | |
| EA201792597A3 (ru) | Производные глутаримидов, их применение, фармацевтическая композиция на их основе, способы их получения | |
| ME02840B (me) | Spojevi fenoksietilpiperidina | |
| MX390763B (es) | Compuestos de tetraciclina | |
| EA201691058A1 (ru) | Производные пирролопирролона и их применение для лечения заболеваний | |
| JP2015516419A5 (member.php) | ||
| EA201490573A1 (ru) | Соединение бензотиазолона | |
| EA201591653A1 (ru) | Композиции для лечения глазных расстройств с применением дипиридамола | |
| PH12016501026A1 (en) | Dosage regimen for an alpha-isoform selective phosphatidylinositol 3-kinase inhibitor | |
| EA201500446A1 (ru) | Фармацевтическая композиция для снижения уровня n-оксида триметиламина | |
| HRP20171514T1 (hr) | Derivati indolouree supstituirani glukopiranozilom i njihova upotreba kao inhibitora sglt |